APA (7th ed.) Citation

M, B., S, B., Z, I., DM, S., A, M., SG, H., . . . CG, L. (2026). Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation. Alzheimer's & dementia (New York, N. Y.), 12(1), e70203. https://doi.org/10.1002/trc2.70203

Chicago Style (17th ed.) Citation

M, Barnwal, Baksh S, Ismail Z, Shade DM, Moghekar A, Ho SG, Rosenberg PB, Porsteinsson AP, and Lyketsos CG. "Blood Biomarkers for Alzheimer's Disease Are Correlated with Measures of Agitation and Cognition in a Randomized Trial Assessing the Effects of Escitalopram on Agitation." Alzheimer's & Dementia (New York, N. Y.) 12, no. 1 (2026): e70203. https://doi.org/10.1002/trc2.70203.

MLA (9th ed.) Citation

M, Barnwal, et al. "Blood Biomarkers for Alzheimer's Disease Are Correlated with Measures of Agitation and Cognition in a Randomized Trial Assessing the Effects of Escitalopram on Agitation." Alzheimer's & Dementia (New York, N. Y.), vol. 12, no. 1, 2026, p. e70203, https://doi.org/10.1002/trc2.70203.